ALLODX
Company News
AlloDx launches CompliTCC™ sC5b-9 test
AlloDx launches CompliTCC™ sC5b-9 test
Read more ↗
AlloDx CompliNeF™ Assay: Reading C3NeF Function Through Bb Retention
2026-09-23 A reliable C3NeF assay should not only reflect the functional changes of C3 convertase, but also minimize the interference of anti-IgG signals. If C3NeF is regarded as an ordinary natural
Read more ↗
Genetic testing should not stop at finding mutations
Core point of view: Detecting variants is only the starting point; only by putting the variants back into the context of kidney disease and kidney transplantation can we form more clinically valuable…
Read more ↗
AlloDx SuperNAT: Advancing Nephrin Antibody Testing in Podocyte Disease
In recent years, Nephrin antibodies have attracted increasing attention from the nephrology community as potential biomarkers for podocyte-related diseases such as minimal change disease (MCD) and…
Read more ↗
AlloDx releases SuperNAT: a new generation of highly sensitive Nephrin antibody test
Recently, AlloDx launched a self-developed second-generation highly sensitive Nephrin antibody detection solution - Super Nephrin AntibodyTrap (SuperNAT for short), which can be used to detect…
Read more ↗
ddcfDNA quantitative technology upgrade!
ddcfDNA is a biomarker of non-invasive injury in kidney transplantation. Its detection accuracy is affected by specific pathological/physiological conditions, such as the patient's pregnancy, tumor…
Read more ↗
New: Comprehensive Genetic Testing for Alport Syndrome
Alport syndrome (AS), also known as hereditary progressive nephritis, is a primary glomerular basement membrane disease caused by mutations in the gene COL4An (n=3, 4, 5) encoding the α3-α5 chain of…
Read more ↗
AlloDx Patents
Title of invention: An immunomagnetic bead and its application in the isolation of renal tubular epithelial cells Patent number: ZL 2021 1 0988884.6 Title of invention: A method for detecting ultra-low frequency mutations in cfDNA
Read more ↗
Good news | The national “Science and Technology Innovation 2030 Major Project” jointly applied for by Zhejiang University, Wuxi People’s Hospital, AlloDx and others was officially launched
Recently, the National Science and Technology Innovation 2030 - "Research on the Prevention and Treatment of Cancer, Cardio-Cerebrovascular, Respiratory and Metabolic Diseases" major project…
Read more ↗
Seminar on clinical application progress of donor-derived cell-free DNA was successfully held
On March 30, an online seminar on clinical application progress of donor-derived cell-free DNA (hereinafter referred to as ddcfDNA) hosted by AlloDx was successfully held. With the theme of "Joining…
Read more ↗
AlloDx and Aishen.com have reached a strategic cooperation to provide more comprehensive services to patients with kidney disease.
Recently, AlloDx and Aishen.com have reached a strategic cooperation - announcing that the two parties will establish an in-depth cooperative relationship in Internet medical care, giving full play…
Read more ↗
The company cooperates with many domestic tertiary hospitals to carry out product academic promotion activities
In order to improve clinical transplantation experts' awareness of the company's "Oin M1" product, and further collect feedback on the current use of clinical products. Recently, our company has…
Read more ↗No matching content. Try another keyword or view all categories.